EW Filing
4Filing Date: May 29, 2026
Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001225208-26-005647open_in_new
Total Value$48.9K
Trades1
Insiders1
Transaction Details
Dahl Andrew M.
SVP, Corporate Controller·Direct
Sell · Dispose
Common Stock
Shares-567.53
Price$86.08
Total Value$48.9K
Shares Owned After15.33K
Transaction DateMay 29, 2026
Post-Transaction Holdings
Dahl Andrew M.
| Security | Shares | Change |
|---|---|---|
| Common Stock | 15.33K | -567.53 (-3.57%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-29
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Dahl Andrew M.
CIK: 0002022347
Role: Officer (SVP, Corporate Controller)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-29 | Code: S (Open market sale)
Shares: -567.5266 | Price: $86.08
Total Value: $48,852.69
Shares Owned After: 15,334.0948 | Ownership: D (Direct)
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-05-29)